Smoking enhances the expression of angiotensin‐converting enzyme 2 involved in the efficiency of severe acute respiratory syndrome coronavirus 2 infection. (2nd November 2022)
- Record Type:
- Journal Article
- Title:
- Smoking enhances the expression of angiotensin‐converting enzyme 2 involved in the efficiency of severe acute respiratory syndrome coronavirus 2 infection. (2nd November 2022)
- Main Title:
- Smoking enhances the expression of angiotensin‐converting enzyme 2 involved in the efficiency of severe acute respiratory syndrome coronavirus 2 infection
- Authors:
- Suzuki, Rigel
Ono, Yuki
Noshita, Koji
Kim, Kwang Su
Ito, Hayato
Morioka, Yuhei
Tamura, Tomokazu
Okuzaki, Daisuke
Tagawa, Tetsuzo
Takenaka, Tomoyoshi
Yoshizumi, Tomoharu
Shimamura, Teppei
Iwami, Shingo
Fukuhara, Takasuke - Abstract:
- Abstract: Smoking is one of the risk factors most closely related to the severity of coronavirus disease 2019 (COVID‐19). However, the relationship between smoking history and severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) infectivity is unknown. In this study, we evaluated the ACE2 expression level in the lungs of current smokers, ex‐smokers, and nonsmokers. The ACE2 expression level of ex‐smokers who smoked cigarettes until recently (cessation period shorter than 6 months) was higher than that of nonsmokers and ex‐smokers with a long history of nonsmoking (cessation period longer than 6 months). We also showed that the efficiency of SARS‐CoV‐2 infection was enhanced in a manner dependent on the angiotensin‐converting enzyme 2 (ACE2) expression level. Using RNA‐seq analysis on the lungs of smokers, we identified that the expression of inflammatory signaling genes was correlated with ACE2 expression. Notably, with increasing duration of smoking cessation among ex‐smokers, not only ACE2 expression level but also the expression levels of inflammatory signaling genes decreased. These results indicated that smoking enhances the expression levels of ACE2 and inflammatory signaling genes. Our data suggest that the efficiency of SARS‐CoV‐2 infection is enhanced by smoking‐mediated upregulation of ACE2 expression level.
- Is Part Of:
- Microbiology and immunology. Volume 67:Number 1(2023)
- Journal:
- Microbiology and immunology
- Issue:
- Volume 67:Number 1(2023)
- Issue Display:
- Volume 67, Issue 1 (2023)
- Year:
- 2023
- Volume:
- 67
- Issue:
- 1
- Issue Sort Value:
- 2023-0067-0001-0000
- Page Start:
- 22
- Page End:
- 31
- Publication Date:
- 2022-11-02
- Subjects:
- ACE2 -- COVID‐19 -- inflammation -- SARS‐CoV‐2 -- smoking
Microbiology -- Periodicals
Immunology -- Periodicals
Allergy and Immunology -- Periodicals
Microbiology -- Periodicals
Microbiologie -- Périodiques
Immunologie -- Périodiques
579 - Journal URLs:
- http://bibpurl.oclc.org/web/42307 ↗
http://bibpurl.oclc.org/web/7904 ↗
http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1348-0421 ↗
http://www.sanbi.co.jp/capj/ ↗
http://www3.interscience.wiley.com/journal/118902525/home ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1111/1348-0421.13034 ↗
- Languages:
- English
- ISSNs:
- 0385-5600
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 5757.791000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 24989.xml